GSK (GSK)

GSK trades at $43.34, pinned near the near-term max pain of $44 expiring Oct 10, 2025 (5 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($25-$45), reflecting growing call interest at higher strikes. Key magnetic zone at 35 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for GSK shows an upward trend from 25 to 45, suggesting bullish positioning in longer-dated options. The 51% spread signals divergent expectations across timeframes. Most levels below 43.34 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.